Trodelvy (sacituzumab govitecan)

pCPA File Number: 21756
Negotiation Status:
Concluded with an LOI
For the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior therapies, at least one of them for metastatic disease
Gilead Sciences Canada Inc.
CDA-AMC Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: